Rosuvastatin Calcium

Product NDC: 50090-4710
11-digit product format: 500904710
Labeler code: 50090
Product ID: 50090-4710_5c15d600-0569-4bc4-84a6-d93541a46983
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Rosuvastatin Calcium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA079170
Marketing category: ANDA
Marketing start: 2016-07-19
Substance: ROSUVASTATIN CALCIUM
Active strength: 5 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-4710-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-4710-0	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-4710-1	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-4710-0	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-4710-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-4710-0	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-4710-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-4710-0	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-4710-1	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-4710-0	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-4710-1	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-4710-0	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A079170-001	ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19
A079170-002	ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19
A079170-003	ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19
A079170-004	ROSUVASTATIN CALCIUM	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A079170-001	AB
A079170-002	AB
A079170-003	AB
A079170-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-001	ROSUVASTATIN CALCIUM	EQ 5MG BASE	TABLET / ORAL	AB	2016-07-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-002	ROSUVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2016-07-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-003	ROSUVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2016-07-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-004	ROSUVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2016-07-19	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A079170-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079170-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079170-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A079170-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A079170-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079170-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079170-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A079170-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A079170-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A079170-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079170-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079170-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A079170-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A079170-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A079170-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A079170-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A079170-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A079170-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A079170-004	AB	1	`d8e5a09893c0…`

Additional Listing Data#

Finished product: Yes
Brand name base: Rosuvastatin Calcium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ROSUVASTATIN CALCIUM	5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
83MVU38M7Q	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
859424	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3debe076-4af2-456f-9c27-8ff81d6aec1b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c8f25656-847a-4de8-96a7-06bf98d83c2b	Product name	1	20210916
b6a872b4-e31a-fff0-6f62-fd0253265e2f	Product name	9	20190618
5a2818e5-ef92-49b1-bc6c-9fe2427d21d5	Product name	1	20190429

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50090-4710-0	2025-01-07	These highlights do not include all the information needed to use ROSUVASTATIN TABLETS safely and effectively. See full prescribing information for ROSUVASTATIN TABLETS. ROSUVASTATIN tablets, for oral use Initial U.S. Approval: 2003
50090-4710-1	2025-01-07	These highlights do not include all the information needed to use ROSUVASTATIN TABLETS safely and effectively. See full prescribing information for ROSUVASTATIN TABLETS. ROSUVASTATIN tablets, for oral use Initial U.S. Approval: 2003
50090-4710-0	2023-01-30	These highlights do not include all the information needed to use ROSUVASTATIN TABLETS safely and effectively. See full prescribing information for ROSUVASTATIN TABLETS. ROSUVASTATIN tablets, for oral use Initial U.S. Approval: 2003
50090-4710-1	2023-01-30	These highlights do not include all the information needed to use ROSUVASTATIN TABLETS safely and effectively. See full prescribing information for ROSUVASTATIN TABLETS. ROSUVASTATIN tablets, for oral use Initial U.S. Approval: 2003

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50090-4710-0	Rosuvastatin Calcium	30 in 1 BOTTLE	TABLET, FILM COATED	30	7
50090-4710-1	Rosuvastatin Calcium	90 in 1 BOTTLE	TABLET, FILM COATED	90	7
50090-4710-2	Rosuvastatin Calcium	100 in 1 BOTTLE	TABLET, FILM COATED	100	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-4710-0	EA - Each	50090-4710	b8570872-f216-495f-8771-56ec91bf721b	1	2025-02-10
50090-4710-1	EA - Each	50090-4710	379372f4-8472-4bf5-92ad-267ac37a07d8	1	2025-02-10
50090-4710-2	EA - Each	50090-4710	9009e31d-d969-4455-9709-983397364e3b	1	2025-02-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-4710	ROSUVASTATIN CALCIUM TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]	7	Current NDC, Legacy NDC, 3 package rows	20250109_3debe076-4af2-456f-9c27-8ff81d6aec1b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 19 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	Aurobindo Pharma Limited	47924917-bbd5-45de-96cb-c7ff9754da97	2026-06-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	NuCare Pharmaceuticals, Inc.	275d4288-064d-d1bd-e063-6294a90a28e1	2026-02-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	Northwind Health Company, LLC	f2b71718-c054-3e05-e053-2995a90a52bf	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	American Health Packaging	b7491a1a-570e-40ea-b65b-f956c9e284a6	2025-10-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	85ed9283-4e16-41bf-95ed-01b62640fd2c	2025-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	Bryant Ranch Prepack	3dd06868-6b71-4ddd-bc9c-57e1cf6656a5	2025-01-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	3debe076-4af2-456f-9c27-8ff81d6aec1b	2025-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170 ndc (product): 50090-4710
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	98bf4f79-2d42-4b69-966b-2275189a4d4d	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	216d8a80-9bc6-493a-90d3-a00926b49572	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	7a969720-7994-43a1-97c0-5e7842ae2be4	2024-12-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	Rising Pharma Holdings, Inc.	5c992d3d-d754-48b6-a267-1451208352ed	2024-12-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	0ec87d67-4fe0-4f5a-aa6b-114042ebc249	2024-10-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	d147d4b2-5c2a-44d2-abb6-e77715f2b0f5	2024-10-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	8030f0bc-fb11-4c85-8058-ed6482689d1a	2024-10-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	NCS HealthCare of KY, LLC dba Vangard Labs	d84f596d-8b99-419c-9a02-4b5e26aeaea8	2024-09-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	6c061ef9-1dcd-4efd-b0ce-6f3ab91b1bc6	2023-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	A-S Medication Solutions	86fde296-d1c5-4fe8-9050-77c074914f63	2023-08-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	Proficient Rx LP	a9478b12-89d2-42a4-a310-707a87ef43d7	2022-08-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170
Rosuvastatin Calcium	ROSUVASTATIN CALCIUM	Proficient Rx LP	3066f572-e3db-4bf8-b9ee-bd32d9ed8c13	2022-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 079170 application number: ANDA079170

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
83MVU38M7Q	ROSUVASTATIN CALCIUM	147098-20-2	ROSUVASTATIN CALCIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
859424	rosuvastatin calcium 5 MG Oral Tablet	PSN	3debe076-4af2-456f-9c27-8ff81d6aec1b	7
859424	rosuvastatin calcium 5 MG Oral Tablet	SCD	3debe076-4af2-456f-9c27-8ff81d6aec1b	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-4710-0	50090471000	30 TABLET, FILM COATED in 1 BOTTLE (50090-4710-0)	2019-11-12	0000-00-00	No	No	Current
50090-4710-1	50090471001	90 TABLET, FILM COATED in 1 BOTTLE (50090-4710-1)	2019-11-12	0000-00-00	No	No	Current
50090-4710-2	50090471002	100 TABLET, FILM COATED in 1 BOTTLE (50090-4710-2)	2024-12-26		No	No	Current